Dipa Healthcare

What Dipa Healthcare does

Dipa Healthcare, operating as PT Dipa Pharmalab Intersains, is an Indonesian private limited company headquartered in Jakarta that manufactures and distributes pharmaceuticals, health supplements, traditional medicines, medical devices, and microbiology/chemical laboratory products. Founded approximately 60 years ago (circa 1966 per company history) and led by founder & chairman Tjipto Pusposuharto, the company operates a vertically integrated model with its cGMP-certified manufacturing plant in Majalengka (West Java), a warehouse in Bekasi, two Jakarta offices, and a nationwide field sales force of 400+ representatives covering pharmacies, hospitals, clinics, and laboratories across Indonesia. The company is certified to ISO 9001:2015, GDP, cGMP, and Halal standards, with each product carrying an Indonesian BPOM registration number.

The company generates revenue through four streams: (1) branded pharmaceutical and health supplement sales under its own multi-brand portfolio (Dipa Pharmalab Intersains, Puspa Pharma, Tomo Kenko, Dipa Puspa Labsains, DIPA ViBEZ); (2) authorized Indonesian distribution of products from 15+ global healthcare principals including Thermo Fisher/Oxoid, Bracco, Medac, Grifols, Engelhard Arzneimittel, Genepharm, Aldo-Union, Lonza, Mylan, Avantor, Vitrolife, OSARTIS, and Tintometer; (3) contract manufacturing services across six dosage forms (soft capsules, semisolids, oral liquids, oral powders, tablets, hard capsules) under three engagement models; and (4) sales of microbiology media and chemical reagents to laboratory customers. The product range spans prescription drugs (e.g., CELEDIP, ETORICOXIB, FEMAPLEX, NOXARIN, HEPAMED, METOJECT), contrast media and biologics (MULTIHANCE, IOMERON, IOPAMIRO, GAMUNEX-C), consumer supplements (ACTIVGLUTA, ASTAXANTHIN, JOINT MAX, TONICARD), herbal/traditional medicines (PROSPAN F, ARUM, OSDEC), and pharmaceutical-grade microbiology media (Tryptone Soya Agar, Sabouraud Dextrose Agar, LAL Assay).

The go-to-market is sales-led through direct field relationships, supplemented by co-marketing partnerships (e.g., PT Bumi Puspa Ceremai for Tomo Kenko supplements) and a corporate website/dipa.co.id digital catalog. Pricing is not publicly disclosed and is quote-based for B2B distribution and contract manufacturing engagements; consumer products are sold through traditional Indonesian pharmaceutical distribution channels. No revenue, funding, or cap table information is publicly disclosed, and the company is privately held under founder family ownership.

Name

Dipa Healthcare

Legal name

PT Dipa Pharmalab Intersains

Website

https://dipa.co.id

Company type

Private

Founded year

1966

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Dipa Healthcare (PT Dipa Pharmalab Intersains) is an Indonesian private pharmaceutical manufacturer and distributor founded circa 1966, headquartered in Jakarta, with a cGMP-certified plant in West Java and a 400+ person nationwide sales force serving pharmacies, hospitals, clinics, and laboratories across Indonesia through proprietary brands, 15+ global principal partnerships, and contract manufacturing services.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing & Distribution

NAICS

Pharmaceutical Preparation Manufacturing (325412), Food Manufacturing (311), Medicinal and Botanical Manufacturing (325411)

SIC

Food And Kindred Products (2000), Pharmaceutical Preparations (2834)

akta.pro primary industry

Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO)

Keywords

• Pharmaceutical manufacturing
• Health supplement distribution
• Medical device distribution
• Microbiology media supply
• Contract manufacturing services

Headquarters

HQ city

Jakarta

HQ country

Indonesia

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Branded pharmaceutical and health supplement sales: Sale of proprietary pharmaceutical products, health supplements, traditional medicines, and medical devices under Dipa's own brands (Dipa Pharmalab Intersains, Puspa Pharma, Tomo Kenko, Dipa Puspa Labsains) distributed across Indonesia through a 400+ nationwide sales force. Includes POM-registered drugs, health supplements, and traditional medicines.
2. Distribution of licensed principal products: Exclusive/local distribution of pharmaceutical, medical device, and microbiology products from global principals (ThermoFisher/Oxoid, BRACCO, MEDAC, GRIFOLS, Engelhard Arzneimittel, Genepharm, Aldo-Union, Lonza, Mylan, Avantor, Vitrolife, OSARTIS, Tintometer, etc.) into the Indonesian market.
3. Contract manufacturing services: Third-party/contract manufacturing services including purchasing existing formulas, developing new formulations/products, and co-marketing or joint marketing of active DIPA products across multiple dosage forms (soft capsules, semisolids, oral liquids, oral powders, tablets, hard capsules).
4. Chemical laboratory and microbiology media sales: Sales of microbiology media and chemical materials needed for drug and food safety testing to laboratory customers.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Dipa Healthcare manufactures and distributes pharmaceuticals, health supplements, traditional medicines, medical devices, microbiology media, and chemical laboratory reagents in Indonesia. It operates a cGMP-certified manufacturing plant covering soft capsules, semisolids, oral liquids, oral powders, tablets, and hard capsules, and serves as the Indonesian distribution partner for global principals such as Thermo Fisher/Oxoid, Bracco, Medac, Grifols, Engelhard, and Lonza. It also offers contract manufacturing services with three engagement models (formula purchase, new formulation development, and co-marketing) at its Majalengka facility, delivered through a 400+ person nationwide field sales force.

Product overview

Dipa Healthcare (PT Dipa Pharmalab Intersains) is a vertically integrated Indonesian healthcare company offering a multi-brand portfolio rather than a single unified software product. Its offerings span three main product families: (1) own-manufactured pharmaceuticals and health supplements under the Dipa, Tomo Kenko, Puspa Pharma, and Bumi Puspa Ceremai brands (e.g., ACTIVGLUTA – TOMO KENKO, TONICARD, FETAVITA, JOINT MAX, PUSPACAL, REBONE FORTE, ASTAXANTHIN – TOMO KENKO, ARUM), including prescription drugs such as CELEDIP, ETORICOXIB, HEPAMED, FEMAPLEX and NOXARIN; (2) chemical laboratory / microbiology products distributed under the Thermo Scientific Oxoid and Remel brands (e.g., Tryptone Soya Agar, Sabouraud Dextrose Agar, Lauryl Tryptose Broth, Egg Yolk Emulsion, Thermo Scientific™ RapID™ ONE System) and Lonza endotoxin testing (Gel Clot LAL Assay); and (3) medical devices / contrast media and biologicals from global principals including Bracco (Iomeron 400, Iopamiro 300/370, MultiHance), Medac (Metoject, Hydroxyurea Medac, Dacarbazine Medac), Grifols (Koate-DVI, HyperHEP B), and Aldo-Union (Dipsamol). Complementing these is a Contract Manufacturing service covering soft capsules, semisolids, oral liquids, powders, tablets, and hard capsules. The three families are delivered through a shared nationwide 400+ sales force and are ISO 9001:2015, GDP, cGMP, and Halal certified.

Differentiator

Problem solved

Functional benefit

Brands

• Tomo Kenko: Sub-brand product line covering health supplements such as ASTAXANTHIN, ACTIVGLUTA, MAGNESIUM, VIT C 500mg, VIT D3, VIT E 400 IU, ZINC+B6, K2D3, and PRO-ZEB.
• DIPA ViBEZ

Products and services

• ACTIVGLUTA – TOMO KENKO Tomokenko-branded health supplement film-coated caplet combining glutathione 500 mg, Vitamin C 200 mg, and Vitamin E 100 IU, intended to help maintain skin health.
• TONICARD Softgel cardio-support health supplement combining Ubidecarenone (CoQ10) 100 mg, L-Carnitine Fumarate 400 mg, Vitamin E 100 IU, and Folic Acid 800 mcg.
• FETAVITA Softgel supplement delivering 400 mg Natural Fish Oil, 100 mg Evening Primrose Oil, 150 IU Vitamin E, and 200 mcg Folic Acid for maternal/fetal nutrition support.
• ASTAXANTHIN – TOMO KENKO Tomokenko-branded softgel supplying Astaxanthin 6 mg per capsule for general health maintenance and antioxidant support.
• HEPA-BALANCE Film-coated caplet liver-support supplement combining Schisandra chinensis extract, Lecithin, Silybum marianum extract, Curcuma domestica extract, and Vitamin B6.
• MAGNESIUM – TOMO KENKO Tomokenko-branded film-coated caplet supplying Magnesium 350 mg to help meet magnesium requirements.
• JOINT MAX Film-coated caplet joint health supplement combining Glucosamine HCl 500 mg, Chondroitin Sulfate 400 mg, MSM, Manganese, Magnesium, Zinc, and Vitamins C and E.
• PUSPACAL Puspa Pharma-branded calcium/Mineral K2D3 film-coated caplet with Lithothamnion corallioides, Vitamin D3, Vitamin K2, Magnesium, Zinc, Glycine Max extract and Boron for bone health.
• REBONE FORTE Sachet-format joint and bone support drink delivering 1,500 mg D-Glucosamine HCl, 1,200 mg Chondroitin Sulfate, 1,000 mg MSM, plus Zinc, Manganese, Magnesium, and Selenium per serving.
• CELEDIP Celecoxib 100 mg / 200 mg capsule COX-2 selective NSAID for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute pain management.

Quantifiable outcome

• 60+ years of operating heritage in Indonesian healthcare
• +2 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

15 partnerships are on record, tiered flagship principal partner for microbiology and laboratory product portfolio, major imaging/contrast media principal partner, major specialty pharma principal partner, major plasma/biologics principal partner, major herbal/otc principal partner, specialty pharma principal partner, respiratory product principal partner, endotoxin testing product principal partner, global pharma principal partner, laboratory supplies principal partner, specialty principal partner, laboratory equipment principal partner, laboratory consumables principal partner and key local co-marketing partner for tomo kenko and selected health supplements.

• Thermo Fisher Scientific (Oxoid / Remel)flagship principal partner for microbiology and laboratory product portfolioStrategic or Co-development PartnerDipa Pharmalab Intersains is the Indonesian distribution partner for Thermo Fisher Scientific's Oxoid and Remel microbiology brands. Dipa distributes Oxoid dehydrated culture media (Tryptone Soya Agar, Sabouraud Dextrose Agar, Buffered Peptone Water, Plate Count Agar, Mac-Conkey Agar No 3, Lauryl Tryptose Broth, Potato Dextrose Agar, Egg Yolk Emulsion), AnaeroGen 2.5L Sachet, and the RapID ONE System identification panel to Indonesian clinical, food, and pharmaceutical labs.
• BRACCOmajor imaging/contrast media principal partnerChannel Partner/ Reseller/ DistributorDipa distributes Bracco's radiology contrast media products in Indonesia, including MultiHance (gadobenate dimeglumine) for liver MRI imaging and Iomeron (iomeprol) iodinated contrast for radiology procedures (CT scans, angiography, arthrography).
• MEDAC GMBHmajor specialty pharma principal partnerChannel Partner/ Reseller/ DistributorDipa distributes Medac GmbH specialty pharmaceuticals in Indonesia, including Methotrexate-based METOJECT (for rheumatoid arthritis and psoriasis), DACARBAZINE MEDAC (chemotherapy), and HYDROXYUREA MEDAC (chronic myeloid leukemia).
• Grifols Therapeutics LLCmajor plasma/biologics principal partnerChannel Partner/ Reseller/ DistributorDipa distributes Grifols biologics in Indonesia, including KOATE-DVI (Antihemophilic Factor / Factor VIII) for hemophilia A and HYPERHEP B (hepatitis B immune globulin).
• Engelhard Arzneimittel GmbH & Co. KGmajor herbal/otc principal partnerChannel Partner/ Reseller/ DistributorDipa imports and markets Engelhard's Prospan F (ivy leaf extract cough syrup) in Indonesia under POM TI246018421 registration; Engelhard is listed as the manufacturer in Germany and Dipa as the Indonesian importer/marketer.
• Genepharmspecialty pharma principal partnerChannel Partner/ Reseller/ DistributorGenepharm-manufactured products distributed by Dipa include DIPROCA (bicalutamide 50 mg) for advanced prostate cancer and FEMAPLEX (letrozole 2.5 mg) for postmenopausal hormone-receptor-positive breast cancer.
• Aldo-Unionrespiratory product principal partnerChannel Partner/ Reseller/ DistributorDipa distributes Aldo-Union's Dipsamol (salbutamol sulfate 100 mcg metered-dose inhaler) in Indonesia for bronchodilation.
• Lonzaendotoxin testing product principal partnerChannel Partner/ Reseller/ DistributorDipa distributes Lonza's Gel Clot LAL Assay in Indonesia for endotoxin testing used in pharmaceutical quality control.
• Mylanglobal pharma principal partnerChannel Partner/ Reseller/ DistributorListed as a global principal whose products are distributed by Dipa Pharmalab Intersains in Indonesia.
• Avantorlaboratory supplies principal partnerChannel Partner/ Reseller/ DistributorListed as one of Dipa's principal partners for laboratory/chemical products distributed into the Indonesian market.
• Vitrolife Sweden ABspecialty principal partnerChannel Partner/ Reseller/ DistributorListed as one of Dipa's principal partners; specialty products distributed into Indonesia.
• OSARTIS GMBHspecialty principal partnerChannel Partner/ Reseller/ DistributorListed as one of Dipa's principal partners for specialty medical products distributed in Indonesia.
• Tintometer LTD / Tintometer GMBHlaboratory equipment principal partnerChannel Partner/ Reseller/ DistributorListed as one of Dipa's principal partners for laboratory colorimetric/water-testing equipment distributed in Indonesia.
• Fraser Micropipette / Fraser Personal Protection & Equipmentlaboratory consumables principal partnerChannel Partner/ Reseller/ DistributorListed as one of Dipa's principal partners for laboratory consumables (micropipettes and PPE) distributed in Indonesia.
• PT Bumi Puspa Ceremaikey local co-marketing partner for tomo kenko and selected health supplementsGTM or Marketing PartnerPT Bumi Puspa Ceremai is listed on Dipa product labels as the marketing/distribution partner (Dipasarkan oleh) for selected Dipa-manufactured health supplement products including ACTIVGLUTA – TOMO KENKO and ASTAXANTHIN – TOMO KENKO in Indonesia, while Dipa Pharmalab Intersains remains the manufacturer (Diproduksi oleh).

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Soho Global Health: Indonesian pharmaceutical and consumer health company manufacturing and marketing branded prescription drugs, OTC products, and supplements through its own distribution network. Highly comparable mid-cap Indonesian pharma manufacturer-distributor with similar branded portfolio and OTC focus.
• Pyridam Farma: Indonesian pharmaceutical manufacturer with branded generics, supplements, and medical devices distributed nationwide. Comparable mid-cap Indonesian pharma manufacturer-distributor with a multi-brand branded portfolio and nationwide field coverage.
• Mensa Group: Privately held Indonesian pharmaceutical manufacturer and distributor producing branded generics, supplements, and traditional medicines. Comparable privately-held Indonesian pharma manufacturer-distributor operating a multi-brand portfolio.
• Otto Pharmaceutical: Indonesian pharmaceutical contract manufacturer offering dosage-form manufacturing (tablets, capsules, liquids, semisolids) for third-party brand owners. Directly comparable to Dipa's contract manufacturing arm, though narrower in dosage-form coverage.
• Phapros: Indonesian state-affiliated pharmaceutical manufacturer of branded generics and supplements with national distribution. Comparable mid-cap Indonesian pharma manufacturer-distributor with similar branded-generic and supplement portfolio.

Broad incumbents

• Dexa Medica: Privately held Indonesian pharmaceutical group with branded generics, supplements, and export operations across Southeast Asia. Comparable to Dipa as a diversified Indonesian pharma manufacturer with a multi-brand portfolio and field-sales distribution, though Dexa has a stronger export footprint.
• Tempo Scan Pacific: Listed Indonesian pharmaceutical and consumer-products group with prescription drugs, OTC, supplements, and contract manufacturing. Comparable vertically integrated Indonesian pharma manufacturer-distributor, though somewhat larger and more diversified into consumer goods.
• Kimia Farma: State-owned Indonesian pharmaceutical manufacturer-distributor with a nationwide pharmacy retail network and significant generic and branded drug operations. Comparable to Dipa in offering a broad branded pharma portfolio plus distribution, though it operates at a larger scale and is partially government-affiliated.
• Kalbe Farma: Indonesia's largest listed pharmaceutical and consumer-health company, offering prescription drugs, OTC, supplements, distribution, and medical devices through its own nationwide sales force. Directly comparable as a vertically integrated Indonesian pharma manufacturer-distributor with branded portfolios, though at materially larger scale.

Regional players

• Indo Farma (Indofarma): Indonesian state-owned pharmaceutical manufacturer and distributor producing branded generics, OTC, and supplements with nationwide distribution. Comparable Indonesian pharma manufacturer-distributor though operating at a somewhat different scale and ownership profile.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/DipaHealthcare.Career
• LinkedInlinkedin.com/company/dipahealthcare
• Instagraminstagram.com/dipa.healthcare
• Xx.com/dipahealthcare

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dipa Healthcare